X-139548455-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong
The NM_000133.4(F9):c.484C>T(p.Arg162*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R162R) has been classified as Pathogenic. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000133.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hemophilia BInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- mild hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- moderately severe hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of hemophilia B in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- thrombophilia, X-linked, due to factor 9 defectInheritance: XL Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| F9 | NM_000133.4 | c.484C>T | p.Arg162* | stop_gained | Exon 5 of 8 | ENST00000218099.7 | NP_000124.1 | |
| F9 | NM_001313913.2 | c.370C>T | p.Arg124* | stop_gained | Exon 4 of 7 | NP_001300842.1 | ||
| F9 | XM_005262397.5 | c.392-2607C>T | intron_variant | Intron 4 of 6 | XP_005262454.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F9 | ENST00000218099.7 | c.484C>T | p.Arg162* | stop_gained | Exon 5 of 8 | 1 | NM_000133.4 | ENSP00000218099.2 | ||
| F9 | ENST00000394090.2 | c.370C>T | p.Arg124* | stop_gained | Exon 4 of 7 | 1 | ENSP00000377650.2 | |||
| F9 | ENST00000643157.1 | n.1151C>T | non_coding_transcript_exon_variant | Exon 3 of 7 | ||||||
| F9 | ENST00000479617.2 | n.*63C>T | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor IX deficiency disease Pathogenic:3
Variant summary: F9 c.484C>T (p.Arg162X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 181435 control chromosomes (gnomAD). c.484C>T has been observed in individuals affected with Factor IX Deficiency (Hemophilia B). The following publication has been ascertained in the context of this evaluation (PMID: 35842956). ClinVar contains an entry for this variant (Variation ID: 10640). Based on the evidence outlined above, the variant was classified as pathogenic.
not specified Pathogenic:1
The F9 c.484C>T; p.Arg162Ter variant (rs137852272), also known as Arg116Ter, has been described in multiple individuals affected with severe hemophilia B (see link to F9 database and references therein, Lin 2018). It contains and entry in ClinVar (Variation ID: 10640) and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered pathogenic. REFERENCES Link to F9 database: http://www.factorix.org/ Lin X et al. Establishing a comprehensive genetic diagnosis strategy for hemophilia B and its application in Chinese population. Int J Lab Hematol. 2018 Apr;40(2):215-228.
Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg162*) in the F9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in F9 are known to be pathogenic (PMID: 20301668). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with hemophilia B (PMID: 32875744). This variant is also known as 17,761C>T 116R>stop. ClinVar contains an entry for this variant (Variation ID: 10640). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at